• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Catalent Inc.

    12/18/24 10:33:58 AM ET
    $CTLT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CTLT alert in real time by email
    S-8 POS 1 d656485ds8pos.htm S-8 POS S-8 POS

    As filed with the Securities and Exchange Commission on December 18, 2024

    Registration No. 333-197726

    Registration No. 333-228438

    Registration No. 333-278578

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT:

    to

    FORM S-8

    POST-EFFECTIVE AMENDMENT No. 1 TO REGISTRATION STATEMENT NO. 333-197726

    POST-EFFECTIVE AMENDMENT No. 1 TO REGISTRATION STATEMENT NO. 333-228438

    POST-EFFECTIVE AMENDMENT No. 1 TO REGISTRATION STATEMENT NO. 333-278578

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    CATALENT, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   20-8737688
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

    14 Schoolhouse Road, Somerset, New Jersey 08873

    (Address of Principal Executive Offices)

    (732) 537-6200

    (Registrant’s telephone number, including area code)

    2007 PTS Holdings Corp. Stock Incentive Plan

    Catalent, Inc. 2014 Omnibus Incentive Plan

    Catalent, Inc. 2018 Omnibus Incentive Plan

    Catalent, Inc. 2019 Employee Stock Purchase Plan

    (Full title of the plan)

    Joseph A. Ferraro

    Senior Vice President, General Counsel, Chief Compliance Officer and Secretary

    Catalent, Inc.

    14 Schoolhouse Road

    Somerset, New Jersey 08873

    (Name and address of agent for service)

    (732) 537-6200

    (Telephone number, including area code, of agent for service)

    Copy to:

    Todd E. Freed

    Richard J. Grossman

    Patrick J. Lewis

    Skadden, Arps, Slate, Meagher & Flom LLP

    One Manhattan West

    New York, New York 10001

    Telephone: (212) 735-3000

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     


    EXPLANATORY NOTE

    Deregistration of Unsold Securities

    This Post-Effective Amendment (this “Post-Effective Amendment”) relates to each of the following Registration Statements on Form S-8 (collectively, the “Prior Registration Statements”) of Catalent, Inc. (the “Company”) which have been previously filed with the U.S. Securities and Exchange Commission (the “SEC”), to deregister any and all securities that remain unsold under each such Registration Statement as of the date hereof:

     

      1.

    Registration Statement No. 333-197726, originally filed with the SEC on July 30, 2014, to register (i) 6,492,080 shares of common stock, par value $0.01 per share, of the Company (the “Common Stock”), issuable pursuant the 2007 PTS Holdings Corp. Stock Incentive Plan, and (ii) 6,700,000 shares of Common Stock issuable pursuant to the Catalent, Inc. 2014 Omnibus Incentive Plan.

     

      2.

    Registration Statement No. 333-228438, originally filed with the SEC on November 16, 2018, to register (i) 15,600,000 shares of Common Stock issuable pursuant to the Catalent, Inc. 2018 Omnibus Incentive Plan, and (ii) 3,800,000 shares of Common Stock issuable pursuant to the Catalent, Inc. 2019 Employee Stock Purchase Plan (the “2019 Plan”).

     

      3.

    Registration Statement No. 333-278578, originally filed with the SEC on April 9, 2024, to register 7,625,000 shares of Common Stock issuable pursuant to the 2019 Plan.

    On December 18, 2024 (the “Effective Date”), pursuant to the Agreement and Plan of Merger, dated as of February 5, 2024, by and among the Company, Creek Parent, Inc., a Delaware corporation (“Parent”), a wholly owned subsidiary of Novo Holdings A/S, and Creek Merger Sub, Inc., a Delaware corporation (“Merger Sub”), Merger Sub merged with and into the Company (the “Merger”), with the Company surviving as a wholly owned subsidiary of Parent.

    As a result of the Merger, the Company has terminated all offerings of its securities pursuant to its existing registration statements, including the Prior Registration Statements. In accordance with an undertaking made by the Company in the Prior Registration Statements to remove from registration by means of a post-effective amendment any and all securities registered under the Prior Registration Statements that remain unsold at the termination of the offerings, the Company hereby removes from registration any securities registered under each Registration Statement which remained unsold as of the Effective Date.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Prior Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in Somerset, New Jersey, on the 18 day of December, 2024.

     

    CATALENT, INC.
    By:   /s/ JOSEPH A. FERRARO
     

    Name:

     

    JosephA. Ferraro

      Title:   Senior Vice President, General Counsel, Chief Compliance Officer & Secretary

    No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.

    Get the next $CTLT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTLT

    DatePrice TargetRatingAnalyst
    11/16/2023$45.00 → $53.00Neutral → Outperform
    Robert W. Baird
    9/5/2023$62.00Hold → Buy
    Argus
    7/20/2023$43.00Equal Weight
    Wells Fargo
    7/5/2023$45.00Neutral
    JP Morgan
    6/14/2023$45.00 → $44.00Buy → Hold
    Jefferies
    5/22/2023$90.00 → $45.00Overweight → Neutral
    JP Morgan
    5/15/2023$55.00 → $29.00Buy → Hold
    Deutsche Bank
    5/8/2023$28.00Neutral → Underperform
    BofA Securities
    More analyst ratings